Search research articles
Contact Us
Filters
Showing results (241-250 of 361) with videos related to
Page
of 37
Sort By:
Assay and Drug Development Technologies
|
April 23, 2009
Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies
J Li, L Lee, Y Gong, et al.
Mutation Research
|
April 1, 1992
Chemical purity and mutagenicity: case study of a drug in development
M L Kropko, J C Jaen, J C Theiss, et al.
Journal of Clinical Pharmacology
|
September 22, 2006
Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men
Danny Soon, Prajakti A Kothare, Helle Linnebjerg, et al.
British Journal of Clinical Pharmacology
|
September 19, 2002
Quinidine does not affect the renal clearance of moxonidine
Stephen D Wise, Clark Chan, Hans G Schaefer, et al.
Biological Psychiatry
|
September 1, 1981
An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity
L E DeLisi, B H Phelps, C D Wise, et al.
Progress in Brain Research
|
August 27, 2011
Reducing surface area while maintaining implant penetrating profile lowers the brain foreign body response to chronically implanted planar silicon microelectrode arrays
John L Skousen, Sr Mary Elizabeth Merriam, Onnap Srivannavit, et al.
Chemical Science
|
March 22, 2018
Large, heterometallic coordination cages based on ditopic metallo-ligands with 3-pyridyl donor groups
Matthew D Wise, Julian J Holstein, Philip Pattison, et al.
Schizophrenia Bulletin
|
January 1, 1980
Sources of error in the determination of platelet monoamine oxidase: a review of methods
C D Wise, S G Potkin, T P Bridge, et al.
Journal of Hepatology
|
November 3, 2004
Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
Danny K W Soon, Stephen L Lowe, Choo Hua Teng, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists
S R Kesten, T G Heffner, S J Johnson, et al.
Page
of 37
Search research articles
Search
Showing results (241-250 of 361) with videos related to
Sort By:
Page
of 37
Assay and Drug Development Technologies
|
April 23, 2009
Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies
J Li, L Lee, Y Gong, et al.
Mutation Research
|
April 1, 1992
Chemical purity and mutagenicity: case study of a drug in development
M L Kropko, J C Jaen, J C Theiss, et al.
Journal of Clinical Pharmacology
|
September 22, 2006
Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men
Danny Soon, Prajakti A Kothare, Helle Linnebjerg, et al.
British Journal of Clinical Pharmacology
|
September 19, 2002
Quinidine does not affect the renal clearance of moxonidine
Stephen D Wise, Clark Chan, Hans G Schaefer, et al.
Biological Psychiatry
|
September 1, 1981
An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity
L E DeLisi, B H Phelps, C D Wise, et al.
Progress in Brain Research
|
August 27, 2011
Reducing surface area while maintaining implant penetrating profile lowers the brain foreign body response to chronically implanted planar silicon microelectrode arrays
John L Skousen, Sr Mary Elizabeth Merriam, Onnap Srivannavit, et al.
Chemical Science
|
March 22, 2018
Large, heterometallic coordination cages based on ditopic metallo-ligands with 3-pyridyl donor groups
Matthew D Wise, Julian J Holstein, Philip Pattison, et al.
Schizophrenia Bulletin
|
January 1, 1980
Sources of error in the determination of platelet monoamine oxidase: a review of methods
C D Wise, S G Potkin, T P Bridge, et al.
Journal of Hepatology
|
November 3, 2004
Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
Danny K W Soon, Stephen L Lowe, Choo Hua Teng, et al.
Journal of Medicinal Chemistry
|
September 10, 1999
Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists
S R Kesten, T G Heffner, S J Johnson, et al.
Page
of 37